MX2020004675A - Formulaciones de alcohol de seda. - Google Patents

Formulaciones de alcohol de seda.

Info

Publication number
MX2020004675A
MX2020004675A MX2020004675A MX2020004675A MX2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A MX 2020004675 A MX2020004675 A MX 2020004675A
Authority
MX
Mexico
Prior art keywords
relates
present
aqueous formulation
alcohol formulations
alcohol
Prior art date
Application number
MX2020004675A
Other languages
English (en)
Inventor
Lin Römer
Jens Klein
Ralf Mehrwald
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of MX2020004675A publication Critical patent/MX2020004675A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La presente invención se relaciona con una formulación acuosa que comprende una proteína estructural y un alcohol. Además, la presente invención se relaciona con un método para producir una formulación acuosa. Además, la presente invención se relaciona con una composición farmacéutica que comprende la formulación acuosa que consiste de una proteína estructural y un alcohol. Además, la presente invención se relaciona con una composición cosmética que comprende la formulación acuosa que comprende una proteína estructural y un alcohol.
MX2020004675A 2017-11-10 2018-11-08 Formulaciones de alcohol de seda. MX2020004675A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17201049 2017-11-10
PCT/EP2018/080557 WO2019092073A1 (en) 2017-11-10 2018-11-08 Silk alcohol formulations

Publications (1)

Publication Number Publication Date
MX2020004675A true MX2020004675A (es) 2020-08-13

Family

ID=60301890

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020004675A MX2020004675A (es) 2017-11-10 2018-11-08 Formulaciones de alcohol de seda.

Country Status (9)

Country Link
US (1) US20200270316A1 (es)
EP (1) EP3706712A1 (es)
JP (2) JP7320846B2 (es)
KR (1) KR20200086328A (es)
CN (1) CN111491613A (es)
BR (1) BR112020009041A2 (es)
MX (1) MX2020004675A (es)
SG (1) SG11202003987VA (es)
WO (1) WO2019092073A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915839D0 (en) 2019-10-31 2019-12-18 Givaudan Sa Hair care composition
WO2023104752A1 (en) * 2021-12-07 2023-06-15 Amsilk Gmbh Use of a structural polypeptide for treating or finishing textiles
CN116425848A (zh) * 2023-04-11 2023-07-14 北京新诚中科技术有限公司 重组嵌合蛛丝蛋白、生物蛋白纤维及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1933021A (en) * 1930-08-07 1933-10-31 Maeder Preparation for use in curling hair
NL7713618A (nl) * 1976-12-11 1978-06-13 Bayer Ag Werkwijze voor de bereiding van een cosmetisch preparaat.
JPS5566929A (en) * 1978-11-13 1980-05-20 Kanebo Ltd Finely-powdered fibroin and its manufacture
JPH04300897A (ja) * 1991-03-28 1992-10-23 Kiyoichi Matsumoto 絹フィブロイン溶液
JP2997758B2 (ja) * 1996-01-23 2000-01-11 農林水産省蚕糸・昆虫農業技術研究所長 創傷被覆材
FR2774588B1 (fr) * 1998-02-11 2000-05-05 Oreal Composition cosmetique ou dermatologique contenant au moins une proteine de soie d'arachnides naturelle, recombinante ou un analogue
JP2000319169A (ja) * 1999-05-13 2000-11-21 Ryoso:Kk 除菌剤とそれを用いた消毒方法
JP2002114616A (ja) 2000-10-12 2002-04-16 Ryoso:Kk 除菌剤とそれを用いた消毒方法
PL1773875T3 (pl) * 2004-07-22 2015-03-31 Amsilk Gmbh Rekombinowane białka jedwabiu pająków
AU2006286753B2 (en) * 2005-08-29 2011-08-18 Amsilk Gmbh Modified spider silk proteins
EP1979055A2 (de) 2006-01-20 2008-10-15 Basf Se Verwendung von protein-microbeads in der kosmetik
US20110008437A1 (en) * 2009-04-20 2011-01-13 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
US20110052695A1 (en) * 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
JP6081908B2 (ja) 2010-03-31 2017-02-15 アーエムシルク ゲーエムベーハー 不溶性の標的タンパク質の分離
CN102429835B (zh) * 2011-11-30 2013-05-01 广州好迪集团有限公司 发用角蛋白定型剂及发用定型品
RU2478706C1 (ru) * 2011-12-23 2013-04-10 Игорь Иванович Агапов Способ получения суспензий гидрогелевых микрочастиц с заданными размерами на основе рекомбинантного белка паутины и их применение
JP6077569B2 (ja) * 2012-12-27 2017-02-08 Ｓｐｉｂｅｒ株式会社 親水性組換えタンパク質の抽出方法
CN104327283B (zh) * 2014-10-16 2017-01-11 苏州经贸职业技术学院 一种复合丝素蛋白水凝胶及其制备方法、应用
US20190275193A1 (en) * 2016-11-11 2019-09-12 Amsilk Gmbh Use of a shrinkable biopolymer fiber as a sensor

Also Published As

Publication number Publication date
KR20200086328A (ko) 2020-07-16
SG11202003987VA (en) 2020-05-28
US20200270316A1 (en) 2020-08-27
JP2021502365A (ja) 2021-01-28
CN111491613A (zh) 2020-08-04
JP2023153832A (ja) 2023-10-18
EP3706712A1 (en) 2020-09-16
JP7320846B2 (ja) 2023-08-04
WO2019092073A1 (en) 2019-05-16
BR112020009041A2 (pt) 2020-11-03

Similar Documents

Publication Publication Date Title
CL2017002727A1 (es) Composiciones de ácido obeticólico y métodos de uso
PE20180782A1 (es) Composiciones de insulina de accion rapida
CR20160141A (es) Formulaciones de anticuerpos anti-pdl1
CL2017002335A1 (es) Composiciones de cosmetica topica para combatir radicales libres
AR060130A1 (es) Formulacion de un anticuerpo monoclonal humano anti- igf-1r
CO2018001628A2 (es) Composiciones y formulaciones antimicrobianas
AR109685A1 (es) Composiciones de nanopartículas y métodos para fabricarlas y usarlas
MX2020004675A (es) Formulaciones de alcohol de seda.
AR098168A1 (es) Formulación estable de insulina glulisina
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
CY1122310T1 (el) Εκχυλισμα γαρδενιας για τον χρωματισμο του δερματος
CL2019002514A1 (es) Composiciones cosméticas para el cuidado de la piel.
MX360084B (es) Composicion de champu que comprende matriz de gel e histidina.
CO2019003424A2 (es) Extracto de planta impregnado de alulosa y método de preparación para el mismo
BR112018012043A2 (pt) processo para a redução da transpiração
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
BR112018008588A2 (pt) composição, e, processo para preparar uma composição.
GEP20237486B (en) Formulations of copanlisib
UY37444A (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y su uso
AR108616A1 (es) Formulación combinada de tres compuestos antivirales
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
BR112019023074A2 (pt) composição contendo ciclodextrina e bussulfano
BR112019000240A2 (pt) composições farmacêuticas
BR112018001793A2 (pt) preparação cosmética de redução do suor
CO2019014831A2 (es) Nuevas formulaciones orales de belinostat